NIH-funded research NIH-funded research

Bioluminescent FAK Sensor and Gene Screen to Map Cell Adhesion

Official title: Bioluminescent FAK Sensor and Genome-Wide CRISPR Knockout Screen to Identify Regulators of Cellular Adhesion

Funded at Central Michigan University · NIH-11381798 · Data updated 2026-11-12

A research team is creating a glowing FAK sensor and scanning the genome to find genes that control how cells stick together and move, which could inform breast cancer biology.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCentral Michigan University
NIH-funded
Lab location1 site (Mount Pleasant, United States)
Project startAugust 1, 2025
Project endMay 31, 2029
Funding year2026
Award (this year)$144,767
NIH project number5R16GM158720-02
Project IDNIH-11381798 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with breast cancer or related cellular models where FAK signaling and adhesion processes are relevant.

Less likely to help

At this stage, it is a basic science study using cell models and does not involve direct patient participation.

What this research studies

Researchers will develop a bioluminescent sensor (BlinKS) to watch FAK kinase activity in living cells in real time and combine this with a genome-wide CRISPR knockout screen to identify regulators of cellular adhesion. The project aims to map the genetic networks that govern how cells attach to and migrate on their surroundings, shedding light on basic cellular biology. Outcomes could point to new molecular targets that influence cancer cell movement and tissue repair. This work is foundational, aiming to translate basic biology insights into potential future cancer therapies.

Why it matters

Potential benefit: If successful, the findings may reveal new targets to hinder cancer cell spread and improve understanding of tissue repair processes.

How similar studies have gone: Previous studies using CRISPR screens and reporter sensors have identified regulators of cell adhesion, supporting the promise of this approach.

Where this research is happening

  • Central Michigan University
    Mount Pleasant, United States
    Active

Researchers

  • Principal investigator: Bakke, Jesse Lee — Central Michigan University
  • Study coordinator: Bakke, Jesse Lee

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.